Skip to main content
. 2022 Nov;84(4):733–745. doi: 10.18999/nagjms.84.4.733

Table 5.

Association between UC in active phase and UC immunological comorbidities (OR, 9.58, 99% CI, 2.52–36.43)

UC active phase UC in remission Total
UC immunological comorbidity 26 5 31
Non-UC immunological comorbidity 51 94 145
Total 77 99 176

UC: ulcerative colitis

OR: odds ratio

CI: confidence interval